These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37515245)

  • 21. COVID-19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients.
    Roberts MB; Izzy S; Tahir Z; Al Jarrah A; Fishman JA; El Khoury J
    Transpl Infect Dis; 2020 Oct; 22(5):e13407. PubMed ID: 32654303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocompromised Seroprevalence and Course of Illness of SARS-CoV-2 in One Pediatric Quaternary Care Center.
    Freeman MC; Rapsinski GJ; Zilla ML; Wheeler SE
    J Pediatric Infect Dis Soc; 2021 Apr; 10(4):426-431. PubMed ID: 33049042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplant in a recently COVID-19 positive child with hepatoblastoma.
    Goss MB; Munoz FM; Ruan W; Galván NTN; O'Mahony CA; Rana A; Cotton RT; Moreno NF; Heczey AA; Leung DH; Goss JA
    Pediatr Transplant; 2021 Aug; 25(5):e13880. PubMed ID: 32979013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients.
    Colmenero J; Rodríguez-Perálvarez M; Salcedo M; Arias-Milla A; Muñoz-Serrano A; Graus J; Nuño J; Gastaca M; Bustamante-Schneider J; Cachero A; Lladó L; Caballero A; Fernández-Yunquera A; Loinaz C; Fernández I; Fondevila C; Navasa M; Iñarrairaegui M; Castells L; Pascual S; Ramírez P; Vinaixa C; González-Dieguez ML; González-Grande R; Hierro L; Nogueras F; Otero A; Álamo JM; Blanco-Fernández G; Fábrega E; García-Pajares F; Montero JL; Tomé S; De la Rosa G; Pons JA
    J Hepatol; 2021 Jan; 74(1):148-155. PubMed ID: 32750442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening.
    Willicombe M; Gleeson S; Clarke C; Dor F; Prendecki M; Lightstone L; Lucisano G; McAdoo S; Thomas D;
    Transplantation; 2021 Jan; 105(1):151-157. PubMed ID: 33196625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the Omicron variant truly less virulent in solid organ transplant recipients?
    Anjan S; Khatri A; Viotti JB; Cheung T; Garcia LAC; Simkins J; Loebe M; Phancao A; O'Brien CB; Sinha N; Ciancio G; Vianna RM; Andrews D; Abbo LM; Guerra G; Natori Y
    Transpl Infect Dis; 2022 Dec; 24(6):e13923. PubMed ID: 35915957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synbiotics, prebiotics and probiotics for solid organ transplant recipients.
    Cooper TE; Scholes-Robertson N; Craig JC; Hawley CM; Howell M; Johnson DW; Teixeira-Pinto A; Jaure A; Wong G
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD014804. PubMed ID: 36126902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 in children treated with immunosuppressive medication for kidney diseases.
    Marlais M; Wlodkowski T; Al-Akash S; Ananin P; Bandi VK; Baudouin V; Boyer O; Vásquez L; Govindan S; Hooman N; Ijaz I; Loza R; Melgosa M; Pande N; Pape L; Saha A; Samsonov D; Schreuder MF; Sharma J; Siddiqui S; Sinha R; Stewart H; Tasic V; Tönshoff B; Twombley K; Upadhyay K; Vivarelli M; Weaver DJ; Woroniecki R; Schaefer F; Tullus K
    Arch Dis Child; 2021 Jul; 106(8):798-801. PubMed ID: 33355203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.
    Khan FL; Nguyen JL; Singh TG; Puzniak LA; Wiemken TL; Schrecker JP; Taitel MS; Zamparo JM; Jodar L; McLaughlin JM
    JAMA Netw Open; 2022 Dec; 5(12):e2246915. PubMed ID: 36515946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
    Thuluvath PJ; Robarts P; Chauhan M
    J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy.
    Patrono D; Lupo F; Canta F; Mazza E; Mirabella S; Corcione S; Tandoi F; De Rosa FG; Romagnoli R
    Transpl Infect Dis; 2020 Oct; 22(5):e13353. PubMed ID: 32500942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation.
    Uemura T; Ramprasad V; Matsushima K; Shike H; Valania T; Kwon O; Ghahramani N; Shah R; Farooq U; Khan A; Kadry Z
    Transplantation; 2011 Sep; 92(6):678-85. PubMed ID: 21841541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies.
    Candel FJ; Salavert M; Lorite Mingot D; Manzano Crespo M; Pérez Portero P; Cuervo Pinto R
    Rev Esp Quimioter; 2023 Aug; 36(4):380-391. PubMed ID: 37089055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anesthetic Complications Associated With Severe Acute Respiratory Syndrome Coronavirus 2 in Pediatric Patients.
    Saynhalath R; Alex G; Efune PN; Szmuk P; Zhu H; Sanford EL
    Anesth Analg; 2021 Aug; 133(2):483-490. PubMed ID: 33886516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omicron BA.4/5 Neutralization and T-Cell Responses in Organ Transplant Recipients After Booster Messenger RNA Vaccine: A Multicenter Cohort Study.
    Ferreira VH; Ierullo M; Mavandadnejad F; Kurtesi A; Hu Q; Hardy WR; Hall VG; Pinzon N; Yotis D; Gingras AC; Belga S; Shalhoub S; Hébert MJ; Humar A; Kabbani D; Kumar D
    Clin Infect Dis; 2023 Jul; 77(2):229-236. PubMed ID: 36975097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.